EUVIMEDEUVIMED entdecken
Crossref

Multi‐Functional AIE Phototheranostic Agent Enhancing α PD‐L1 Response for Oral Squamous Cell Carcinoma Immunotherapy

Yuewen Yu, Zihui Ni, Yanbin Xu, Le Zhang, Yucheng Liu, Fanrui Zeng, Ming Zhang, Laikui Liu, Guangxue Feng, Ben Zhong Tang iD

Small · 2024

DOI: 10.1002/smll.202405470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yuewen Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial. Key Laboratory of Luminescence from Molecular Aggregates, School of …. Hauptthemen laut MEDLINE: Immunotherapy, Mouth Neoplasms, B7-H1 Antigen, Reactive Oxygen Species. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Shenzhen Key Laboratory of Functional Aggregate Materials.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) represents a prevalent head and neck malignancy with surgical intervention as the primary clinical option. Immunotherapy, particularly immune checkpoint blockade (ICB) targeting PD‐1/PD‐L1 shows great promise but is impeded by the immunosuppressive tumor microenvironment and low PD‐L1 expression in OSCC. Herein, the “all‐in‐one” phototherapeutic nanoparticles (TSD NPs) are reported with balanced reactive oxygen species and photothermal conversion capacity for combined photoimmunotherapy and ICB immunotherapy against OSCC. A novel electron acceptor, 3‐(dicyanomethylene)‐2,3‐dihydrobenzothiophene‐1,1‐dioxide (DTM), is introduced to develop the phototherapeutic agent with aggregation‐induced emission (AIE) feature and NIR‐II fluorescence centered at 1000 nm. Benefiting from the AIE feature and the DTM acceptor, the resultant TSD NPs also exhibit strong type I reactive oxygen species (ROS) generation and high photothermal conversion efficiency (45.3%), which can profoundly induce immunogenic cell death (ICD), activate cytotoxic T lymphocytes, and convert the immunosuppressive tumor microenvironment into an immune‐supportive one. Additionally, TSD NPs upregulate the PD‐L1 expression on OSCC cells, thus enhancing the efficacy of combined treatment with α PD‐L1 ICB immunotherapy. This results show that the synergistic treatment of TSD NPs and α PD‐L1 effectively eradicates solid OSCC tumors without adverse effects on normal tissues, proving a novel and promising strategy for OSCC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyMouth NeoplasmsB7-H1 AntigenReactive Oxygen SpeciesCarcinoma, Squamous CellHumansAnimalsCell Line, TumorPhototherapyNanoparticlesMiceTheranostic NanomedicineTumor Microenvironment

Stichwörter der Autor:innen

aggregation‐induced emissionimmune checkpoint blockade immunotherapyoral squamous cell carcinomaphototherapeutic agentsphoto‐immunotherapy

Substanzen

B7-H1 AntigenReactive Oxygen SpeciesCD274 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial. Key Laboratory of Luminescence from Molecular Aggregates, School of Materials Science and Engineering, AIE Institute, South China Universi…
  • State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing Medical University, Nanjing,…
  • School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.

ORCID-Profile: Ben Zhong Tang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Shenzhen Key Laboratory of Functional Aggregate Materials
  • China Postdoctoral Science Foundation
  • Nature Science Foundation of Jiangsu Province
  • Research project of Jiangsu Health Commission
  • Jiangsu Province Key Laboratory of Oral Diseases
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Yu, Y., Ni, Z., Xu, Y., Zhang, L., Liu, Y., Zeng, F., Zhang, M., Liu, L., Feng, G., & Tang, B. Z. (2024). Multi‐Functional AIE Phototheranostic Agent Enhancing α PD‐L1 Response for Oral Squamous Cell Carcinoma Immunotherapy. Small. https://doi.org/10.1002/smll.202405470

Vancouver

Yu Y, Ni Z, Xu Y, Zhang L, Liu Y, Zeng F, et al. Multi‐Functional AIE Phototheranostic Agent Enhancing α PD‐L1 Response for Oral Squamous Cell Carcinoma Immunotherapy. Small. 2024. doi:10.1002/smll.202405470

BibTeX
@article{Yu2024,
  author = {Yu, Yuewen and Ni, Zihui and Xu, Yanbin and Zhang, Le and Liu, Yucheng and Zeng, Fanrui and Zhang, Ming and Liu, Laikui and Feng, Guangxue and Tang, Ben Zhong},
  title = {Multi‐Functional AIE Phototheranostic Agent Enhancing α PD‐L1 Response for Oral Squamous Cell Carcinoma Immunotherapy},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202405470}
}
Kostenlos starten →